Whitepaper
6 Feb 2020
Phase II Formulation Case Study
PDF 745 kB
Content provided by our supplier
Tedor Pharma Inc.
-
US -
2018On CPHI since
Other Content from Tedor Pharma Inc. (3)
-
Brochure TEDOR Capabilities Presentation
Brief overview of TEDOR capabilities -
Brochure FLEXITAB Presentation
Complete overview of FLEXITAB patented breakable extended release technology -
Whitepaper Case Studies
3 oral solid dose case studies; 1) Extended Release; Triple API Combination Capsule Product; 3) Poorly Soluble API
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance